National Library of Medicine; Notice of Meetings, 49288-49289 [07-4215]
Download as PDF
49288
Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, MBRS Support of Competitive
Research.
Date: September 17, 2007.
Time: 8 a.m. to 5 p.m.
Agenda; To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: John J Laffan, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Natcher Building, Room 3AN18J,
Bethesda, MD 20892, 301–594–2773.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS)
Dated: August 21, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4219 Filed 8–27–07; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
pwalker on PROD1PC71 with NOTICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
VerDate Aug<31>2005
19:52 Aug 27, 2007
Jkt 211001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Unsolicited Immunology
Single Project Application.
Date: September 19, 2007.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3123, Bethesda, MD 20817 (Telephone
conference Call).
Contact Person: Alec Ritchie, PhD,
Scientific Review Administrator, DHHS/NIH/
NIAID/DEA Scientific Review Program,
6700B Rockledge Drive MSC 7616, Room
3123, Bethesda, MD 20892, 301–435–1614,
aritchie@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 21, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4220 Filed 8–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
BILLING CODE 4140–01–M
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice
is hereby given of meetings of the Board
of Scientific Counselors, National
Center for Biotechnology Information.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual other
conducted by the National Library of
Medicine, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Board of Scientific
Counselors, National Center for
Biotechnology Information, Working Group
on Chemical Information Resource
Coordination.
Date: October 1, 2007.
Open: 1 p.m. to 5 p.m.
Agenda: Discussion on NLM/NCBI
PubChem Database.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD,
Director, National Center for Biotechnology
Information, National Library of Medicine,
Department of Health and Human Services,
Building 38A, Room 8N805, Bethesda, MD
20894, 301–435–5985.
dlipman@mail.nih.gov.
Name of Committee: Board of Scientific
Counselors, National Center for
Biotechnology Information.
Date: October 2, 2007.
Open: 8:30 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 5 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD,
Director, National Center for Biotechnology
Information, National Library of Medicine,
Department of Health and Human Services,
Building 38A, Room 8N805, Bethesda, MD
20894, 301–435–5985.
dlipman@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statements to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
E:\FR\FM\28AUN1.SGM
28AUN1
Federal Register / Vol. 72, No. 166 / Tuesday, August 28, 2007 / Notices
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assisance, National Institutes of Health,
HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4215 Filed 8–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meetings
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel; G08–R01–
R21.
Date: October 15, 2007.
Time: 1 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20817 (Telephone Conference Call).
Contact Person: Zoe E. Huang, MD, Health
Scientific Administrator, Extramural
Programs, National Library of Medicine,
Rockledge 1 Building, 6705 Rockledge Drive,
Suite 301, Bethesda, MD 20892–7968, 301–
594–4937, huangz@mail.nih.gov.
Name of Committee: Biomedical Library
and Informatics Review Committee.
Date: November 6–7, 2007.
Time: November 6, 2007, 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 9000
Rockville Pike, Bethesda, MD 20894.
Time: November 7, 2007, 8 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Aug<31>2005
19:52 Aug 27, 2007
Jkt 211001
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 9000
Rockville Pike, Bethesda, MD 20894.
Contact Person: Arthur A. Petrosian, PhD,
Scientific Review Administrator, Division of
Extramural Programs, National Library of
Medicine, 6705 Rockledge Drive, Suite 301,
Bethesda, MD 20892–7968, 301–496–4253,
petrosia@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs. hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–4223 Filed 8–27–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: FDA Cleared Pediatric Cancer
Diagnostics and Prognostics
National Institutes of Health,
Public Health Service, HHS.
ACTION: Notice.
AGENCY:
SUMMARY: This is notice, in accordance
with 35 U.S.C. 209(c)(1) and 37 CFR
404.7(a)(1)(I), that the National
Institutes of Health (NIH), Department
of Health and Human Services, is
contemplating the grant of an exclusive
license to practice the invention
embodied in Patent Applications U.S.
10/133,937, filed 04/25/2002, entitled
‘‘Methods for Analyzing High
Dimensional Data for Classifying,
Diagnosing, Prognosticating and/or
Predicting Diseases and Other Biological
States’’; and U.S. 10/159,563, filed 05/
31/2002, entitled ‘‘Selections of Genes
And Methods of Using The Same For
Diagnosis And For Targeting The
Therapy of Select Cancers’’; to Althea
Technologies, Inc. having a place of
business in San Diego, California. The
patent rights in this invention have been
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
49289
assigned to the United States of America
(PHS ref E–324–2001/0,1).
DATE: Only written comments and/or
application for a license that are
received by the NIH Office of
Technology Transfer on or before
October 29, 2007 will be considered.
ADDRESS: Requests for a copy of the
patent application, inquiries, comments
and other materials relating to the
contemplated license should be directed
to: Cristina Thalhammer-Reyero, Ph.D.,
M.B.A., Office of Technology Transfer,
National Institutes of Health, 6011
Executive Boulevard, Suite 325,
Rockville, MD 20852–3804; e-mail:
ThalhamC@mail.nih.gov; Telephone:
301–435–4507; Facsimile: 301–402–
0220.
SUPPLEMENTARY INFORMATION: The
prospective exclusive license will be
royalty bearing and will comply with
the terms and conditions of 35 U.S.C.
209 and 37 CFR 404.7. The prospective
exclusive license may be granted unless,
within 60 days from the date of this
published Notice, NIH receives written
evidence and argument that establishes
that the grant of the license would not
be consistent with the requirements of
35 U.S.C. 209 and 37 CFR 404.7.
The invention relates to a method of
using supervised pattern recognition
methods for classifying, diagnosing,
predicting, or prognosticating various
diseases. The method includes
obtaining high dimensional
experimental data, such as gene
expression profiling data, filtering the
data, reducing the dimensionality of the
data through use of one or more
methods, training artificial neural
networks (ANN, a supervised pattern
recognition method), ranking individual
data points from the data, choosing
multiple data points from the data based
on the relative ranking, and using the
multiple data points to determine if an
unknown set of experimental data
indicates a diseased condition, a
predilection for a diseased condition, or
a prognosis about a diseased condition.
Further, the invention relates to sets of
genes expressed in cancer cells that
function to characterize each cancer
type, and methods of using the sets of
genes for diagnosis and for targeting the
therapy of selected cancers. In
particular, the methods apply to classify
cancers which often present diagnostic
dilemmas in clinical practice, such as
the pediatric small round blue cell
tumors (SRBCTs), including
neuroblastoma (NB),
rhabdomyosarcoma (RMS), Burkitt’s
lymphoma (BL), and the Ewing family
of tumors (EWS). Specifically, the
invention is an application of ANNs for
E:\FR\FM\28AUN1.SGM
28AUN1
Agencies
[Federal Register Volume 72, Number 166 (Tuesday, August 28, 2007)]
[Notices]
[Pages 49288-49289]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-4215]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of meetings of
the Board of Scientific Counselors, National Center for Biotechnology
Information.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and evaluation of individual other
conducted by the National Library of Medicine, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Center for Biotechnology Information, Working Group on Chemical
Information Resource Coordination.
Date: October 1, 2007.
Open: 1 p.m. to 5 p.m.
Agenda: Discussion on NLM/NCBI PubChem Database.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD, Director, National Center
for Biotechnology Information, National Library of Medicine,
Department of Health and Human Services, Building 38A, Room 8N805,
Bethesda, MD 20894, 301-435-5985. dlipman@mail.nih.gov.
Name of Committee: Board of Scientific Counselors, National
Center for Biotechnology Information.
Date: October 2, 2007.
Open: 8:30 a.m. to 12 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Closed: 12 p.m. to 2 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Open: 2 p.m. to 5 p.m.
Agenda: Program Discussion.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20892.
Contact Person: David J. Lipman, MD, Director, National Center
for Biotechnology Information, National Library of Medicine,
Department of Health and Human Services, Building 38A, Room 8N805,
Bethesda, MD 20894, 301-435-5985. dlipman@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statements to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
[[Page 49289]]
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.879,
Medical Library Assisance, National Institutes of Health, HHS)
Dated: August 22, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-4215 Filed 8-27-07; 8:45 am]
BILLING CODE 4140-01-M